Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neuroscience Letters

• Publication date

  2004-06-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NEULET.2004.03.074PMID 15157991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neural transplantation for the treatment of Parkinson's disease.

  2003cited by this paper
• Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells

  2003cited by this paper
• Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression

  2003cited by this paper
• Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.

  2002cited by this paper
• The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro.

  2002cited by this paper
• Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell‐derived inducing activity

  2002cited by this paper
• Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development

  2002cited by this paper
• Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease

  2002cited by this paper
• GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons.

  2001cited by this paper
• Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells.

  2001cited by this paper
• Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons

  2001cited by this paper
• Experimental models of Parkinson's disease

  2001cited by this paper
• Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

  2000cited by this paper
• Neurotechnique Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell-Derived Inducing Activity

  2000cited by this paper
• Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells

  2000cited by this paper
• Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

  2000cited by this paper
• Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

  1999cited by this paper
• Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

  1997cited by this paper
• Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

  1990cited by this paper
• Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

  1970cited by this paper

• Electrochemical Detection of Dopamine Release from Living Neurons Using Graphene Oxide-Incorporated Polypyrrole/Gold Nanocluster Hybrid Nanopattern Arrays.

  2023cites this paper
• Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research

  2022cites this paper
• In tube immunocytochemistry for fluorescence-activated cell sorting that prevents RNA degradation in sorted cells

  2020cites this paper
• Grafted Miniature-Swine Neural Stem Cells of Early Embryonic Mesencephalic Neuroepithelial Origin can Repair the Damaged Neural Circuitry of Parkinson's Disease Model Rats.

  2018cites this paper
• A Case Study of Non- Union of Right Second Metatarsal Bone by Using Activated Platelet Rich Plasma Gel

  2018cites this paper
• Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models.

  2018cites this paper
• Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke

  2017cites this paper
• Endogenous Neural stem Cells and Neurological Disorders

  2017cites this paper
• Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

  2015cites this paper
• Anti-Parkinson Activity

  2015cites this paper
• Graphene oxide promotes the differentiation of mouse embryonic stem cells to dopamine neurons.

  2014cites this paper
• An Improved Protocol for mRNA Quantification After Fluorescence-Activated Cell Sorting with an Increased Signal to Noise Ratio in Flow Cytometry

  2014cites this paper
• Insulin induces long-term depression of VTA dopamine neurons via an endocannabinoid-mediated mechanism

  2013cites this paper
• Nuclear Reprogramming and Stem Cells

  2012cites this paper
• miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression

  2012influential citation
• GABAergic Neurons from Mouse Embryonic Stem Cells Possess Functional Properties of Striatal Neurons In Vitro, and Develop into Striatal Neurons In Vivo in a Mouse Model of Huntington’s Disease

  2012cites this paper
• Cellular Programming and Reprogramming: Sculpting Cell Fate for the Production of Dopamine Neurons for Cell Therapy

  2012cites this paper
• Embryonic Stem Cells: Development and Characterization

  2012cites this paper
• Induced Pluripotent Stem Cells in Brain Diseases

  2012cites this paper
• Prospects for Cell Replacement Therapies for Neurodegenerative Diseases

  2012cites this paper
• The differentiation of embryonic stem cells seeded on PCL / gelatin scaffolds accompanied by matrigel into dopaminergic neurons

  2012cites this paper
• Cell-Based Assays in High-Throughput Screening for Drug Discovery

  2012cites this paper
• Prospects and Limitations of Using Endogenous Neural Stem Cells for Brain Regeneration

  2011cites this paper
• Regenerative Medicine for Diseases of the Retina

  2011cites this paper
• Generation of Neural Cells from Pluripotent Stem Cells

  2011cites this paper
• Physiological Properties of Neurons Derived from Human Embryonic Stem Cells Using a Dibutyryl Cyclic AMP-Based Protocol

  2011cites this paper
• Directed Differentiation into Neural Lineages and Therapeutic Potential of Porcine Embryonic Stem Cells in Rat Parkinson's Disease Model

  2010cites this paper
• Messenger RNA quantification after fluorescence‐activated cell sorting using in situ hybridization

  2010cites this paper
• Transplantation of galectin‐1‐expressing human neural stem cells into the injured spinal cord of adult common marmosets

  2010cites this paper
• Messenger RNA quantification after fluorescence activated cell sorting using intracellular antigens.

  2010cites this paper
• Stem cell-derived dopamine neurons for brain repair in Parkinson's disease.

  2010cites this paper
• Molecular and cellular determinants for generating ES-cell derived dopamine neurons for cell therapy.

  2009cites this paper
• Human embryonic stem cells which express hrGFP in the undifferentiated state and during dopaminergic differentiation

  2009cites this paper
• Cellular remyelinating therapy in multiple sclerosis.

  2009cites this paper
• Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling.

  2009cites this paper
• Simultaneous detection of mRNA and protein stem cell markers in live cells

  2009cites this paper
• Cell-based Therapeutic Approaches for Parkinson's Disease: Progress and Perspectives

  2009cites this paper
• ENVIRONMENTAL CUE‐DEPENDENT DOPAMINERGIC NEURONAL DIFFERENTIATION AND FUNCTIONAL EFFECT OF GRAFTED NEUROEPITHELIAL STEM CELLS IN PARKINSONIAN BRAIN

  2009cites this paper
• Ludwig Institute for Cancer Research and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden GENERATION OF DOPAMINE NEURONS IN VIVO AND FROM EMBRYONIC STEM CELLS IN VITRO

  2009cites this paper
• Tissue Transplantation for Parkinson’s Disease

  2009cites this paper
• Generation of dopamine neurons in vivo and from embryonic stem cells in vitro

  2009cites this paper
• Lineage Selection of Functional and Cryopreservable Human Embryonic Stem Cell‐Derived Neurons

  2008cites this paper
• Derive and conquer: sourcing and differentiating stem cells for therapeutic applications

  2008cites this paper
• Microbioreactors for high-throughput cytotoxicity assays.

  2008cites this paper
• Approaches to improving brain protection in cardiac and aortic surgery : an experimental study in a porcine model with hypertonic saline dextran, levosimendan, leukocyte depleting filter and different acid base management strategies

  2008cites this paper
• Chemically defined sequential culture media for TH+ cell derivation from human embryonic stem cells.

  2008cites this paper
• Assessment of Stromal‐Derived Inducing Activity in the Generation of Dopaminergic Neurons from Human Embryonic Stem Cells

  2008cites this paper
• Postnatally Derived Ventral Midbrain Dopamine Neuron Cultures as a Model System for Studying Neurotoxicity and Parkinson's Disease

  2008cites this paper
• The Future of Deep Brain Stimulation

  2008cites this paper
• Embryonic Stem Cell‐Derived Pitx3‐Enhanced Green Fluorescent Protein Midbrain Dopamine Neurons Survive Enrichment by Fluorescence‐Activated Cell Sorting and Function in an Animal Model of Parkinson's Disease

  2008cites this paper
• Neural stem cells: involvement in adult neurogenesis and CNS repair

  2008cites this paper
• Perspectives of use of bone marrow cells in future therapy of brain diseases Mo/liwo0ci wykorzystania komórek szpiku kostnego w przyszøej terapii chorób mózgu

  2007cites this paper
• Bone marrow stromal cells in traumatic brain injury (TBI) therapy: true perspective or false hope?

  2007cites this paper
• Title: Selection of embryonic stem cell derived eGFP+ dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations

  2007cites this paper
• THE DOPAMINERGIC NIGROSTRIATAL SYSTEMAND PARKINSON'S DISEASE: MOLECULAR EVENTSIN DEVELOPMENT, DISEASE, AND CELL DEATH, AND NEW THERAPEUTIC STRATEGIES

  2007cites this paper
• Selection of Embryonic Stem Cell‐Derived Enhanced Green Fluorescent Protein‐Positive Dopamine Neurons Using the Tyrosine Hydroxylase Promoter Is Confounded by Reporter Gene Expression in Immature Cell Populations

  2007cites this paper
• Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells.

  2007cites this paper
• Trophism of neural progenitor cells to embryonic stem cells: Neural induction and transplantation in a mouse ischemic stroke model

  2007cites this paper
• Markers and Methods for Cell Sorting of Human Embryonic Stem Cell‐Derived Neural Cell Populations

  2007cites this paper
• Induction of Dopamine-Releasing Cells from Primate Embryonic Stem Cells Enclosed in Agarose Microcapsules

  2007cites this paper
• Early specification of dopaminergic phenotype during ES cell differentiation

  2007cites this paper
• Use of stem cells for the treatment of multiple sclerosis

  2007cites this paper
• The role of stem cells in Parkinson's disease.

  2007cites this paper
• The Sox2 Regulatory Region 2 Functions as a Neural Stem Cell-specific Enhancer in the Telencephalon*

  2006cites this paper
• Efficient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers.

  2006cites this paper
• Fluorescence-Activated Single Cell Sorting of Human Embryonic Stem Cells

  2006cites this paper
• Embryonic Stem Cells for Grafting in Parkinson's Disease

  2006cites this paper
• In vitro Differenzierung und Aufreinigung ES-Zell-abgeleiteter neuronaler Vorläuferzellen der Maus

  2006cites this paper
• Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson's Disease

  2006cites this paper
• A method for a more complete in vitro Parkinson's model: slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit.

  2006cites this paper
• Transplantation of embryonic neuroectodermal progenitor cells into the site of a photochemical lesion: immunohistochemical and electrophysiological analysis.

  2006cites this paper
• Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson’s disease

  2006cites this paper
• Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation

  2006cites this paper
• Transplantation of Human Embryonic Stem Cell‐Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation

  2006cites this paper
• Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.

  2005cites this paper
• Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.

  2005cites this paper
• Stem cells: classifications, controversies, and clinical applications.

  2005cites this paper
• Derivation of germ cells from mouse embryonic stem cells.

  2005cites this paper
• Engineering a Dopaminergic Phenotype in Stem/Precursor Cells: Role of Nurr1, Glia‐Derived Signals, and Wnts

  2005cites this paper
• Cripto as a Target for Improving Embryonic Stem Cell–Based Therapy in Parkinson's Disease

  2005cites this paper
• Stem cells for the treatment of myelin loss.

  2005cites this paper
• Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.

  2005cites this paper
• Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease

  2005cites this paper
• In Vivo and In Vitro Tissue‐Specific Expression of Green Fluorescent Protein Using the Cre‐Lox System in Mouse Embryonic Stem Cells

  2005cites this paper
• Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: Implications for the engineering of a human TH minimal promoter assembled in a self‐inactivating lentiviral vector system

  2005cites this paper
• Stem cells may reshape the prospect of Parkinson's disease therapy.

  2005influential citation
• New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

  2005cites this paper
• Stem cell treatment for Parkinson's disease: an update for 2005

  2005cites this paper
• Neural precursor cells differentiated from mouse embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease.

  2004cites this paper
• Insulin Induces Long-term Depression of Vta Dopamine Neurons via an Endocannabinoid-mediated Mechanism Pubmed Central Canada Supplementary Material

  year unknowncites this paper